Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
14.4 MOUNJARO Use in Combination with Basal Insulin with or without Metformin in Adult Patients with Type 2 Diabetes Mellitus SURPASS-5 (NCT04039503) was a 40-week double-blind trial that randomized 475 adult patients with type 2 diabetes mellitus with inadequate glycemic control on insulin glargine 100 units/mL, with or without metformin, to subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or placebo
Tirzepatide / Niacinamide Injection Tirzepatide / Niacinamide Injection (4 mL Vial) Tirzepatide / Niacinamide Injection (2.5 mL Vial) Tirzepatide / Niacinamide Injection (2 mL Vial) Product Overview Tirzepatide / Niacinamide Injection is a compounded formulation that combines the dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide with the B-vitamin derivative niacinamide
It is a costly one
You either inject the full dose or you do not inject at all
In three months, people typically lose about 10-15% of their body weight
US$ 25.78
US$ 22.96
US$ 22.83
US$ 23.18
US$ 28.38
US$ 27.34
US$ 24.39
US$ 26.23
US$ 26.17
US$ 22.11
